Iridex (IRIX) Return on Capital Employed Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -846.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,318.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -247.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 362.00 |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn | 2,018.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 2,018.00 |
| Jan 3, 2026 | 1,827.00 |
| Sep 27, 2025 | 4,258.00 |
| Jun 28, 2025 | 3,800.00 |
| Mar 29, 2025 | 2,642.00 |
| Dec 28, 2024 | 308.00 |
| Sep 28, 2024 | -5,469.00 |
| Jun 29, 2024 | -4,530.00 |
| Mar 30, 2024 | -2,898.00 |
| Apr 1, 2023 | 362.00 |
| Dec 31, 2022 | 1,085.00 |
| Oct 1, 2022 | 1,346.00 |
| Jul 2, 2022 | 1,574.00 |
| Apr 2, 2022 | 1,991.00 |
| Jan 1, 2022 | 2,281.00 |
| Oct 2, 2021 | 3,384.00 |
| Jul 3, 2021 | 3,865.00 |
| Apr 3, 2021 | 1,732.00 |
| Mar 28, 2020 | -1,908.00 |
| Dec 28, 2019 | -2,816.00 |
| Sep 28, 2019 | -2,891.00 |
| Jun 29, 2019 | -3,438.00 |
| Mar 30, 2019 | -3,387.00 |
| Dec 29, 2018 | -3,560.00 |
| Sep 29, 2018 | -5,362.00 |
| Jun 30, 2018 | -6,001.00 |
| Mar 31, 2018 | -5,430.00 |
| Sep 30, 2017 | -3,198.00 |
| Jul 1, 2017 | -2,621.00 |
| Apr 1, 2017 | -1,982.00 |
| Dec 31, 2016 | -1,721.00 |
| Oct 1, 2016 | -1,732.00 |
| Jul 2, 2016 | -894.00 |
| Apr 2, 2016 | -627.00 |
| Jan 2, 2016 | -79.00 |
| Oct 3, 2015 | 463.00 |
| Jul 4, 2015 | 96.00 |
| Apr 4, 2015 | 175.00 |
| Sep 27, 2014 | -125.00 |